 |
| sperm count test market |
The global sperm count test market is estimated to be valued at US$ 517.5 Mn in 2023 and is expected to exhibit a CAGR of 12. % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
A sperm count test measures the concentration of sperm in a man's ejaculate. It
helps to determine male fertility issues and ability to impregnate. The test
can be conducted at home or clinical labs using basic or advanced equipment and
reagents.
Market key trends:
The advent of mobile-based sperm testing technologies is one of the key trends
fuelling the sperm count test market growth. Several start-ups are developing
smartphone-based microscopy devices integrated with artificial intelligence to
enable rapid automated analysis of sperm samples at home without requiring
trained technicians. These devices offer convenient monitoring of sperm health
with just a drop of semen anywhere, anytime compared to visiting a clinical
lab. Their growing popularity is expected to facilitate widespread adoption of
sperm count testing especially in underdeveloped areas.
Segment Analysis
The global sperm count test market is segmented based on product, sample, end
user, and region. Based on product, the market is categorized into at-home test
kits, laboratory products & services, and OTC consumables. The at-home test
kits segment dominates the market as these kits enable self-testing by
providing accurate and quick results. By sample, the market is divided into blood,
urine, and semen samples. The semen sample segment holds the largest share as
it is the direct source for analyzing sperm health. Based on end user, the
market covers homecare, fertility clinics, and hospitals. Fertility clinics are
leading the segment owing to preference for professional medical assistance
regarding fertility issues.
Key Takeaways
The global Sperm
Count Test Market Share is expected to witness high growth, exhibiting
a CAGR of 12% over the forecast
period, due to increasing infertility concerns worldwide.
Regional analysis: North America dominates the global market, accounting for
more than 35% share. This is attributed to growing adoption of emerging
diagnostic technologies and availability of advanced healthcare facilities.
Asia Pacific is expected to witness the fastest growth due to rising disposable
incomes, increasing medical tourism, and growing healthcare expenditure in
emerging economies of China and India.
Key players: Key players operating in the sperm count test market are LLC Medical
Group, Abbot Laboratories, CooperSurgical Inc., Hamilton Thorne Ltd., Medical
Electronic Systems, Microptic S.L., ContraVac INC, MotilityCount Aps, DNA
Diagnostics Center, Prestige Consumer Healthcare, Sandstone Diagnostics,
bioMerieux SA, ASKA Pharmaceuticals, Clinical Genetics Pty Ltd, Halotech DNA,
SAS MARKit, Trak Fertility, UEBE Medical GmbH, Vitrolife, and Welling Home
Health.
Read More,
https://www.ukwebwire.com/sperm-count-test-market-trends-size-and-share-analysis/
0 Comments